Research and Development to Discover Cost-effective Regenerative Medicines on the Rise

Jul 16 16:54 2017 Deepak Bandal Print This Article

Over the last decade, the need to discover new applications and enhance the effect and efficiency of the current regenerative medicines has shown a significant growth. Researchers and scientists are turning their focus to manufacture cost-effective and effective drugs that could potentially help in the treatment of several medical conditions and diseases.

Regenerative medicines have gained immense popularity in the last decade. The progress and advancements in the medical field have propelled the growing popularity of the same. The ability to replace,Guest Posting repair and regenerate tissues and organs that are affected by a disease, injury or natural ageing has boosted the potential of regenerative medicines in the future. Regenerative medicines find applications in a wide range of physical disorders and biological problems such as dermatology, cardiovascular and neurodegenerative diseases and other orthopedic applications. In the current scenario, research and development is focused on the development of technologies that are solely based on biologics, somatic, genes and stem cells. Stem cells has received added importance in the industry as they are capable of proliferation. A recent report published by Allied Market Research offers useful insights related to the regenerative medicine market. It discusses the current trends, growth opportunities and the major challenges of the market in detail.

New regenerative medicine center funded by NIH

The recently developed interdisciplinary health science resource center of University of Michigan was awarded a sum of $11.7 million for the research and development activities of regenerative medicine. The project was funded by the National Institutes of Health. The new facility will help in bringing scientists, clinicians and engineers from the university in a collaboration with the research team at the University of Pittsburgh, Harvard University and a few private companies involved in the advancement of regenerative medicines. One of the major objectives of the project is to seek new methods to restore dental, oral and the craniofacial tissues that were lost or damaged in an injury, affected by a disease or congenital disorders. The research project also involves participants from the Medical School, College of Pharmacy, School of Public Health, Office of Technology Transfer and Michigan Institute for Clinical and Health Research, and the College of Engineering.

Study of regenerative medicines involves a thorough research that combines engineering and biology. The research involves identifying damaged cells, organs and tissues that require regeneration and help them become fully functional. Researchers are also exploring different methods to heal wounds at a rapid pace and to repair bones that are damaged. The strategies used for research can either be cell-based, research-based, material-based or the combination of all of the aforementioned strategies. Tiny polymer-based scaffold is used in material-based research in craniofacial field. The polymer-based scaffold are utilized to help in the growth of a damaged bone or a periodontal tissue that highly supports tooth-replacement dental implants. The overall aim of the entire project is to formulate new strategies and medical devices that are likely to help in the process of repairing or regenerating damaged tissues namely, muscle and blood vessels, salivary glands, craniofacial bone and nerves.

The regenerative medicine market is staring at a bright future owing to several initiatives taken by scientists, researchers, genetic engineers and other industry experts to develop and discover new cost-effective and efficient regenerative medicines. Several universities, medical colleges, and industry experts are joining hands to seek novel and innovative regenerative medicines to replace or regenerate multiple medical injuries and body parts. Research and development activities has also witnessed a growth in the last ten years owing to advanced tools and technology. Currently, developed economies such as the U.S. has been the frontrunner in terms of research and initiatives in the field of regenerative medicines. Increase in funding, joint ventures and research projects directed towards the development of regenerative medicines is the prime factor for the popularity of these medicines in the U.S. However, Asia-Pacific is making progress in the field of medical technology. For instance three academic and business firms in Japan are hoping to carry out clinical studies on stem cells and are also aiming to commercialize regenerative therapy.


Source: Free Guest Posting Articles from

About Article Author

Deepak Bandal
Deepak Bandal

Deepak Bandal is a keynote senior consultant on digital marketing at Allied Market Research. He has been recognized for developing a robust social network strategy for the company. Bandal has written several whitepapers, case studies, and articles. He is a visiting faculty member at various educational institutions and has expertise in life sciences and medical devices.

View More Articles